{"disease":{"id":"hemorrhagic-stroke-intracerebral","name":"hemorrhagic stroke intracerebral"},"drugs":{"marketed":[],"pipeline":[],"offLabel":[],"totalMarketed":0,"totalPipeline":0},"trials":{"data":[{"nct_id":"NCT03481777","title":"Remote Ischemic Conditioning in Patients With Acute Stroke (RESIST)","phase":"NA","overall_status":"COMPLETED","enrollment_count":1500,"lead_sponsor_name":"Grethe Andersen","has_results":true},{"nct_id":"NCT07052045","title":"One-Stop manaGemEnT For A Swift Initiation of Endovascular Therapy","phase":"NA","overall_status":"RECRUITING","enrollment_count":390,"lead_sponsor_name":"Prof. Dr. Jan Liman","has_results":false},{"nct_id":"NCT04496076","title":"COVID-19 Brain Injury","phase":"","overall_status":"COMPLETED","enrollment_count":300,"lead_sponsor_name":"University of Pittsburgh","has_results":false},{"nct_id":"NCT07225101","title":"Evaluation of the Efficacy of STRATAFIX for Neurosurgical Cranial and Spine Procedures","phase":"PHASE4","overall_status":"RECRUITING","enrollment_count":160,"lead_sponsor_name":"University of Michigan","has_results":false},{"nct_id":"NCT05671874","title":"Feasibility of a Digital Goals-of-Care Decision Aid for Clinicians and Families of Patients With SABI","phase":"NA","overall_status":"ACTIVE_NOT_RECRUITING","enrollment_count":50,"lead_sponsor_name":"University of Massachusetts, Worcester","has_results":false},{"nct_id":"NCT07132996","title":"Spleen Volume Change Predicts 45-Day Mortality in Neurocritical Care: A Prospective Cohort Study","phase":"","overall_status":"COMPLETED","enrollment_count":42,"lead_sponsor_name":"Ankara City Hospital Bilkent","has_results":false},{"nct_id":"NCT03338998","title":"Efficacy, Safety and Tolerability of BAF312 Compared to Placebo in Patients With Intracerebral Hemorrhage (ICH).","phase":"PHASE2","overall_status":"COMPLETED","enrollment_count":32,"lead_sponsor_name":"Novartis Pharmaceuticals","has_results":true},{"nct_id":"NCT06899464","title":"Safety and Feasibility of Using Cerebrolysin in the Treatment of Primary Intracerebral Hemorrhage - a Prospective Randomized Open Blinded End-point Trial","phase":"PHASE4","overall_status":"NOT_YET_RECRUITING","enrollment_count":30,"lead_sponsor_name":"Cardinal Stefan Wyszynski University","has_results":false},{"nct_id":"NCT05148663","title":"CCM Blood Biomarker Validation Study","phase":"","overall_status":"TERMINATED","enrollment_count":12,"lead_sponsor_name":"Texas Tech University Health Sciences Center, El Paso","has_results":false},{"nct_id":"NCT03371329","title":"Mesenchymal Stem Cells Therapy in Patients With Recent Intracerebral Hemorrhage","phase":"PHASE1","overall_status":"COMPLETED","enrollment_count":9,"lead_sponsor_name":"Mayo Clinic","has_results":false}],"total":10},"guidelines":[],"source":"Drug Landscape verified database"}